Supplement Dose Escalation Trials Help Foster Success – NCCAM’s Berman
This article was originally published in The Tan Sheet
Executive Summary
Initial dose escalation trials will improve the success rate of dietary supplement clinical trials, according to director of NCCAM's Office of Clinical & Regulatory Affairs, Jonathan Berman, MD, PhD